You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
方盛製藥(603998.SH):公司產品藤黃健骨片中選集中帶量採購
格隆匯 08-07 11:43

格隆匯8月7日丨有投資者向方盛製藥(603998.SH)提問:公司是否有產品進入中藥集採,對公司有什麼影響?

方盛製藥回覆:2023年6月21日,公司參加了全國中成藥採購聯盟集中帶量採購信息公開大會。根據全國中成藥聯合採購辦公室發佈的《全國中成藥採購聯盟集中帶量採購擬中選結果公示》顯示,公司產品藤黃健骨片中選本次集中帶量採購。

本次藥品集中帶量採購是全國中成藥採購聯盟集中帶量採購,在執行上要求醫療機構優先使用集中採購中選品種,並確保完成約定採購量。本次中選產品價格雖然與原價相比有一定程度下降,但在後續實施中,預計將進一步擴大公司產品的市場佔有率,提升終端滲透率,有利於強化集采頭部企業的產品集中度,有望對公司未來經營產生積極影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account